Tag

PrEP

PROUD Study Proves PrEP’s Efficacy In Real World Setting

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
Findings from a new open-label trial of pre-exposure prophylaxis (PrEP) could help erase any lingering doubts around the drug’s efficacy in preventing HIV infection outside of a controlled study environment. The PROUD study, which took place at 13 English sexual health clinics, was an open-label trial of PrEP, as opposed to the randomized placebo-controlled studies that have previously shown PrEP’s power in HIV prevention. In an open-label trial, all participants know that they are receiving the actual drug in question and not a placebo. The study was published in The Lancet, one of the world’s leading medical journals. A total 
Read More

White House Releases Updated National HIV/AIDS Strategy

By | Fenway Health Newsroom, Health Care, HIV/AIDS, LGBT Health | No Comments
On July 30, President Obama announced the release of the National HIV/AIDS Strategy: Updated to 2020 at Atlanta’s Morehouse School of Medicine. This first update to the National HIV/AIDS Strategy, originally launched in 2010, is focused on efforts to eradicate HIV in the United States through new preventative tools like pre-exposure prophylaxis (PrEP), as well as ways to vastly improve the quality of life for those already living with the virus. The 2020 goals as outlined in the update include the promotion of widespread testing and linkage to care, which will enable those living with HIV to access treatment early. 
Read More

Fenway Staff Present PrEP, HIV Research At IAS 2015

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
The 2015 International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention is underway this week, and Fenway Health staff are in Vancouver to present important research findings from new studies on HIV prevention and care. One of these studies, titled Absence of Sexual Behavioral Disinhibition in a PrEP Adherence Trial: Considerations for Medical Providers who Prescribe PrEP for Men Who Have Sex with Men (MSM), explores whether Pre-Exposure Prophylaxis (PrEP) MSM users are more likely to engage in condomless sex. When users received a counseling intervention by a trained nurse before initiating PrEP, adherence rates were an impressive 84% 
Read More

Three Years Later, PrEP Education Remains Critical

By | Fenway Health Newsroom, HIV/AIDS, LGBT Health | No Comments
July 16, 2015 marks the third anniversary of FDA’s approval of pre-exposure prophylaxis (PrEP) for use in HIV prevention. In the years since the pill, also commonly known as Truvada, has become available to the public, HIV researchers and public health advocates have declared it one of the greatest tools available in the battle to end HIV/AIDS for good. Prophylaxis refers to the prevention of disease infection and spread, and that is exactly what PrEP is designed to achieve. People take PrEP to keep the HIV infection from taking hold in the case of exposure to the virus. PrEP is 
Read More
CDC logo

CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m for ‘Getting To Zero’ HIV Prevention Partnership

By | Fenway Health Newsroom, Fenway News, HIV/AIDS | No Comments
The United States Centers for Disease Control and Prevention have awarded Fenway Health, AIDS Action Committee of Massachusetts, and the Multicultural AIDS Coalition $3.78 million for a five-year HIV prevention partnership that will focus on gay, bisexual, and other men who have sex with men (MSM) and transgender women, the  groups at highest risk of HIV infection in the US.  Dubbed ‘Getting to Zero,’ the initiative will target hard-to-reach, high risk members of these communities and connect them to HIV counseling and testing, health care, and prevention services. “Massachusetts is one of the few places in the country where HIV 
Read More